- News Releases
The Breast Cancer Genome Guided Therapy Study (BEAUTY Project) will help physicians tailor chemotherapy to breast cancer patients based on their individual genomes and the genomes of their tumors.
Mayo Clinic researchers will obtain three whole genome sequences: one from the patients’ healthy cells before treatment and two tumor genomes – one before chemotherapy and one after. Patients will be paired with mouse “avatars” that will help physicians identify the best treatment for each person.
“What is so exciting about this study is that it has the potential to really bring individualized medicine to our patients,” says Matthew Goetz, M.D., Mayo oncologist and study co-leader. “It will transform how we conduct breast cancer research and how drug therapies are delivered to women with breast cancer.”
Click here for entire news release.
The 2022 SPARK scholars gather for a photo before the Mayo Clinic SPARK Mini Science Fair on Mayo Clinic's campus in Jacksonville, Florida. Back row: ...
In January 2021, after being in remission from melanoma for almost a decade, Christina Armendariz began to feel unwell. The 42-year-old mother went to the emergency ...
Changes to your breast can cause a lot of worry. This is understandable. But not all breast changes are a result of breast cancer. Any breast ...